Register Here

Lead Sponsor

Imaging Endpoints

Featured Executive Sponsor

Natera

Executive Sponsors

10x Genomics
Adaptive Biotechnologies
Clario
Halloran Consulting Group
Immunai
Parexel
Personalis
TD2
Ultivue

Associate Sponsors

Cello Health
GE Healthcare
Fate Therapeutics
Invicro
Scimega
Syneos Health
Worldwide Clinical Trials

Supporting Sponsors

Axiom Healthcare Services
Bio-Techne
MetaVi Labs / FastTrack AI
Nilogen

Exhibitors

Rules-Based Medicine
Teiko Bio

Educational Partners

Alliance for Regenerative Medicine
Center for Biotechnology
Journal of Immunotherapy and Precision Oncology (JIPO)

Supporting Partner

Cancer Research Institute
Savvy

Media Partners

Big 4 Bio

Overview

IO360˚convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.


 

The 8th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

  1. Access to KOLs driving the science
  2. Partnership opportunities with all stakeholders in Immuno-Oncology
  3. Presentations on the latest data impacting the science, clinical and business advancements in Immuno-Oncology

Keynotes

Key Topic Areas

Featured Speakers

 

 

Strategic Advisors


Join the conversation early and become part of the IO360° community by following us on LinkedIn and by following the conference hashtag #IO360nyc. If you are interested in participating in the 8th Annual Immuno-Oncology 360° 2022 program, please contact us at service@tcfllc.org. Thank you.

Sincerely,​

kate-bw-3

Kate Woda
Conference Director

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Strategic Partnerships

elizabeth-bard-bw-2

Elizabeth Bard
Senior Strategic Partnership Manager

Bre Bugbee
Senior Marketing Manager

Adam Kolanko
Strategic Partnership Manager

Meg

Madison Childs
Client Success Manager

Danny McCarthy
IO360° Writer/Editor


Testimonials

  • "By bringing together groups such as scientists, investors, and experts in clinical trial design and logistics, it creates a forum where there’s quite a lot of folks participating who are not traditionally talking to one another on a daily basis."

    - Roy Baynes, MD, PhD, Merck

  • "I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."

    - Jacqueline Karmel, Roche

  • "Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."

    - Christine Ward, BMS

  • "IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"

    - Jim Mansfield, PerkinElmer

  • "Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"

    - Gilson Baia, PhD, Champions Oncology

  • "Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an impressive speaking faculty."

    - Eileen Daniels, Nektar Therapeutics

  • "Thank you for a great conference!"

    - Elena Spanjaard, Pfizer

  • "Your team did a wonderful job in putting together an interesting and relevant program."

    - Lew Bender, Intensity Therapeutics

  • "It was a great conference and I was happy to be a part of it."

    - Anna Pavlick, DO, MD, NYU Cancer Center